SeaStar Medical Holding Corporation
ICU
$0.9709
-$0.1191-10.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 337.31% | -1.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 337.31% | -1.47% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 337.31% | -1.47% | |||
| SG&A Expenses | -19.66% | -4.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.87% | 6.85% | |||
| Operating Income | 19.82% | -6.98% | |||
| Income Before Tax | 14.71% | 1.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.64% | 1.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.64% | 1.32% | |||
| EBIT | 19.82% | -6.98% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 51.26% | 18.03% | |||
| Normalized Basic EPS | 51.31% | 18.03% | |||
| EPS Diluted | 51.26% | 18.03% | |||
| Normalized Diluted EPS | 51.31% | 18.03% | |||
| Average Basic Shares Outstanding | 75.15% | 20.39% | |||
| Average Diluted Shares Outstanding | 75.15% | 20.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||